eye rot semaglutide Ozempic Side Effects: Blepharitis, Swelling & Dermatitis Weight-Loss Drugs May Raise Risk

In the current review, we discussed the dysregulation of IGF-1/GLP-1 signaling in neurodegenerative manifestations of ALS like a genetic anomaly, oligodendrocyte degradation, demyelination, glial overactivation, immune deregulation, and neuroexcitation

The recent approval of OZEMPIC reinforces the growing trend of GLP-1 drugs being used for conditions beyond diabetes and weight loss.

This issue of the HPCs DataPoints series explores trends in GLP-1 prescriptions in Massachusetts through September 2023 and examines the use and spending impacts of these drugs in the Commonwealth.

Professor Ania Jastreboff, MD, PhD Yale University provided an overview #ADA2026 of the TRIUMPH-1 trial for Retatrutide, the investigational triple G medicine from Eli Lilly and Company The unique trial design provided insights beyond #weightloss #obesity and also encompassed relevant endpoints for co-morbidities such as knee osteoarthritis and obstructive sleep apnea, two comorbidities highly sensitive to weight loss

Ford TC, Downey LA, Simpson T, McPhee G, Oliver C, Stough C